Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13 entries
Sorted by: Best Match Show Resources per page
Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop.

Leukemia & lymphoma

Williams ME, Connors JM, Dreyling MH, Gascoyne RD, Kahl BS, Leonard JP, Press OW, Wilson WH.
PMID: 21133727
Leuk Lymphoma. 2011 Jan;52(1):24-33. doi: 10.3109/10428194.2010.532893. Epub 2010 Dec 06.

Mantle cell lymphoma (MCL) is an aggressive B-cell non-Hodgkin lymphoma typically characterized by cyclin D1 overexpression as result of the t(11;14) translocation. MCL is biologically and clinically heterogeneous and frequently involves extranodal dissemination. Although MCL is incurable with current...

Cite
Williams ME, Connors JM, Dreyling MH, et al. Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop. Leuk Lymphoma. 2010;52(1):24-33doi: 10.3109/10428194.2010.532893.
Williams, M. E., Connors, J. M., Dreyling, M. H., Gascoyne, R. D., Kahl, B. S., Leonard, J. P., Press, O. W., & Wilson, W. H. (2011). Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop. Leukemia & lymphoma, 52(1), 24-33. https://doi.org/10.3109/10428194.2010.532893
Williams, Michael E, et al. "Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop." Leukemia & lymphoma vol. 52,1 (2011): 24-33. doi: https://doi.org/10.3109/10428194.2010.532893
Williams ME, Connors JM, Dreyling MH, Gascoyne RD, Kahl BS, Leonard JP, Press OW, Wilson WH. Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop. Leuk Lymphoma. 2011 Jan;52(1):24-33. doi: 10.3109/10428194.2010.532893. Epub 2010 Dec 06. PMID: 21133727; PMCID: PMC7357185.
Copy Download .nbib Format: NLM
[Leukaemic phase of Mantle zone (intermediate) lymphoma--case report--].

Srpski arhiv za celokupno lekarstvo

Vidović A, Suvajcić N, Jovanović V, Janković G.
PMID: 17972826
Srp Arh Celok Lek. 1994 Mar-Apr;122(3):113-5.

Leukaemic phase of non-Hodgkin lymphoma (NHL) is characterised by penetration of lymphoma cells from the originating tissues (lymph nodes, less commonly the spleen) into the peripheral blood and bone marrow. The diagnosis of leukaemic phase of Mantle zone lymphoma...

Cite
Vidović A, Suvajcić N, Jovanović V, et al. Leukemijska faza intermdijarnog ("mantl-zon") limfoma--prikaz bolesnika. [Leukaemic phase of Mantle zone (intermediate) lymphoma--case report--]. Srp Arh Celok Lek. 1994;122(3):113-5
Vidović, A., Suvajcić, N., Jovanović, V., & Janković, G. (1994). Leukemijska faza intermdijarnog ("mantl-zon") limfoma--prikaz bolesnika. [Leukaemic phase of Mantle zone (intermediate) lymphoma--case report--]. Srpski arhiv za celokupno lekarstvo, 122(3), 113-5.
Vidović, A, et al. "Leukemijska faza intermdijarnog ("mantl-zon") limfoma--prikaz bolesnika." [Leukaemic phase of Mantle zone (intermediate) lymphoma--case report--]. Srpski arhiv za celokupno lekarstvo vol. 122,3 (1994): 113-5.
Vidović A, Suvajcić N, Jovanović V, Janković G. Leukemijska faza intermdijarnog ("mantl-zon") limfoma--prikaz bolesnika. [Leukaemic phase of Mantle zone (intermediate) lymphoma--case report--]. Srp Arh Celok Lek. 1994 Mar-Apr;122(3):113-5. Serbian. PMID: 17972826.
Copy Download .nbib Format: NLM
Mantle Cell Lymphoma: Contemporary Diagnostic and Treatment Perspectives in the Age of Personalized Medicine.

Hematology/oncology and stem cell therapy

Sandoval-Sus JD, Sotomayor EM, Shah BD.
PMID: 28404221
Hematol Oncol Stem Cell Ther. 2017 Sep;10(3):99-115. doi: 10.1016/j.hemonc.2017.02.003. Epub 2017 Apr 06.

Mantle cell lymphoma is a clinically heterogeneous disease occurring within a heterogeneous patient population, highlighting a need for personalized therapy to ensure optimal outcomes. It is therefore critical to understand the benefits and risks associated with both intensive and...

Cite
Sandoval-Sus JD, Sotomayor EM, Shah BD. Mantle Cell Lymphoma: Contemporary Diagnostic and Treatment Perspectives in the Age of Personalized Medicine. Hematol Oncol Stem Cell Ther. 2017;10(3):99-115doi: 10.1016/j.hemonc.2017.02.003.
Sandoval-Sus, J. D., Sotomayor, E. M., & Shah, B. D. (2017). Mantle Cell Lymphoma: Contemporary Diagnostic and Treatment Perspectives in the Age of Personalized Medicine. Hematology/oncology and stem cell therapy, 10(3), 99-115. https://doi.org/10.1016/j.hemonc.2017.02.003
Sandoval-Sus, Jose D, et al. "Mantle Cell Lymphoma: Contemporary Diagnostic and Treatment Perspectives in the Age of Personalized Medicine." Hematology/oncology and stem cell therapy vol. 10,3 (2017): 99-115. doi: https://doi.org/10.1016/j.hemonc.2017.02.003
Sandoval-Sus JD, Sotomayor EM, Shah BD. Mantle Cell Lymphoma: Contemporary Diagnostic and Treatment Perspectives in the Age of Personalized Medicine. Hematol Oncol Stem Cell Ther. 2017 Sep;10(3):99-115. doi: 10.1016/j.hemonc.2017.02.003. Epub 2017 Apr 06. PMID: 28404221.
Copy Download .nbib Format: NLM
Management of mantle cell lymphoma.

Annals of hematology

Meusers P, Hense J.
PMID: 10602892
Ann Hematol. 1999 Nov;78(11):485-94. doi: 10.1007/s002770050545.

No abstract available.

Cite
Meusers P, Hense J. Management of mantle cell lymphoma. Ann Hematol. 1999;78(11):485-94doi: 10.1007/s002770050545.
Meusers, P., & Hense, J. (1999). Management of mantle cell lymphoma. Annals of hematology, 78(11), 485-94. https://doi.org/10.1007/s002770050545
Meusers, P, and Hense, J. "Management of mantle cell lymphoma." Annals of hematology vol. 78,11 (1999): 485-94. doi: https://doi.org/10.1007/s002770050545
Meusers P, Hense J. Management of mantle cell lymphoma. Ann Hematol. 1999 Nov;78(11):485-94. doi: 10.1007/s002770050545. PMID: 10602892.
Copy Download .nbib Format: NLM
Case report: blastic Mantle Cell Leukemia.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Bilgir O, Bilgir F, Eliyatkin N, Calan M, Ercan IA, Isikyakar T, Sari F.
PMID: 21855414
Transfus Apher Sci. 2011 Oct;45(2):157-60. doi: 10.1016/j.transci.2011.07.010. Epub 2011 Aug 19.

The patient, who was being followed up for Mantle Cell Lymphoma, was diagnosed with Mast Cell Leukemia 2 years after receiving R-CHOP treatment. The results of flow cytometry, which was performed upon determining leucocytosis and detecting blasts in the...

Cite
Bilgir O, Bilgir F, Eliyatkin N, et al. Case report: blastic Mantle Cell Leukemia. Transfus Apher Sci. 2011;45(2):157-60doi: 10.1016/j.transci.2011.07.010.
Bilgir, O., Bilgir, F., Eliyatkin, N., Calan, M., Ercan, I. A., Isikyakar, T., & Sari, F. (2011). Case report: blastic Mantle Cell Leukemia. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 45(2), 157-60. https://doi.org/10.1016/j.transci.2011.07.010
Bilgir, Oktay, et al. "Case report: blastic Mantle Cell Leukemia." Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis vol. 45,2 (2011): 157-60. doi: https://doi.org/10.1016/j.transci.2011.07.010
Bilgir O, Bilgir F, Eliyatkin N, Calan M, Ercan IA, Isikyakar T, Sari F. Case report: blastic Mantle Cell Leukemia. Transfus Apher Sci. 2011 Oct;45(2):157-60. doi: 10.1016/j.transci.2011.07.010. Epub 2011 Aug 19. PMID: 21855414.
Copy Download .nbib Format: NLM
Recent advances in mantle cell lymphoma: report of the 2013 Mantle Cell Lymphoma Consortium Workshop.

Leukemia & lymphoma

Gordon LI, Bernstein SH, Jares P, Kahl BS, Witzig TE, Dreyling M.
PMID: 24512319
Leuk Lymphoma. 2014 Oct;55(10):2262-70. doi: 10.3109/10428194.2013.876634. Epub 2014 Apr 17.

Mantle cell lymphoma (MCL) is an aggressive B-cell non-Hodgkin lymphoma characterized by overexpression of cyclin D1 resulting from the t(11;14) chromosomal translocation. MCL is biologically and clinically heterogeneous and frequently disseminates to extranodal areas. MCL remains a clinically challenging...

Cite
Gordon LI, Bernstein SH, Jares P, et al. Recent advances in mantle cell lymphoma: report of the 2013 Mantle Cell Lymphoma Consortium Workshop. Leuk Lymphoma. 2014;55(10):2262-70doi: 10.3109/10428194.2013.876634.
Gordon, L. I., Bernstein, S. H., Jares, P., Kahl, B. S., Witzig, T. E., & Dreyling, M. (2014). Recent advances in mantle cell lymphoma: report of the 2013 Mantle Cell Lymphoma Consortium Workshop. Leukemia & lymphoma, 55(10), 2262-70. https://doi.org/10.3109/10428194.2013.876634
Gordon, Leo I, et al. "Recent advances in mantle cell lymphoma: report of the 2013 Mantle Cell Lymphoma Consortium Workshop." Leukemia & lymphoma vol. 55,10 (2014): 2262-70. doi: https://doi.org/10.3109/10428194.2013.876634
Gordon LI, Bernstein SH, Jares P, Kahl BS, Witzig TE, Dreyling M. Recent advances in mantle cell lymphoma: report of the 2013 Mantle Cell Lymphoma Consortium Workshop. Leuk Lymphoma. 2014 Oct;55(10):2262-70. doi: 10.3109/10428194.2013.876634. Epub 2014 Apr 17. PMID: 24512319.
Copy Download .nbib Format: NLM
Resolving confusion: the new realities of mantle cell lymphoma.

Oncology (Williston Park, N.Y.)

O'Connor OA.
PMID: 19711583
Oncology (Williston Park). 2009 Jul;23(8):690-1.

No abstract available.

Cite
O'Connor OA. Resolving confusion: the new realities of mantle cell lymphoma. Oncology (Williston Park). 2009;23(8):690-1
O'Connor, O. A. (2009). Resolving confusion: the new realities of mantle cell lymphoma. Oncology (Williston Park, N.Y.), 23(8), 690-1.
O'Connor, Owen A. "Resolving confusion: the new realities of mantle cell lymphoma." Oncology (Williston Park, N.Y.) vol. 23,8 (2009): 690-1.
O'Connor OA. Resolving confusion: the new realities of mantle cell lymphoma. Oncology (Williston Park). 2009 Jul;23(8):690-1. PMID: 19711583.
Copy Download .nbib Format: NLM
[Mantle cell lymphoma: an overview from diagnosis to future therapies].

La Revue de medecine interne

Le Gouill S.
PMID: 20488592
Rev Med Interne. 2010 Sep;31(9):615-20. doi: 10.1016/j.revmed.2009.05.016. Epub 2010 May 21.

Mantle cell lymphoma (MCL) is a rare non-Hodgkin lymphoma (NHL) entity. The translocation between chromosomes 11 and 14 is the cytogenetics hallmark of MCL. This translocation leads to the dysregulation of the CCDN1 gene, and overexpression of cyclin D1...

Cite
Le Gouill S. Le lymphome à cellules du manteau : du diagnostic aux perspectives thérapeutiques. [Mantle cell lymphoma: an overview from diagnosis to future therapies]. Rev Med Interne. 2010;31(9):615-20doi: 10.1016/j.revmed.2009.05.016.
Le Gouill, S. (2010). Le lymphome à cellules du manteau : du diagnostic aux perspectives thérapeutiques. [Mantle cell lymphoma: an overview from diagnosis to future therapies]. La Revue de medecine interne, 31(9), 615-20. https://doi.org/10.1016/j.revmed.2009.05.016
Le Gouill, S. "Le lymphome à cellules du manteau : du diagnostic aux perspectives thérapeutiques." [Mantle cell lymphoma: an overview from diagnosis to future therapies]. La Revue de medecine interne vol. 31,9 (2010): 615-20. doi: https://doi.org/10.1016/j.revmed.2009.05.016
Le Gouill S. Le lymphome à cellules du manteau : du diagnostic aux perspectives thérapeutiques. [Mantle cell lymphoma: an overview from diagnosis to future therapies]. Rev Med Interne. 2010 Sep;31(9):615-20. doi: 10.1016/j.revmed.2009.05.016. Epub 2010 May 21. French. PMID: 20488592.
Copy Download .nbib Format: NLM
Mantle cell lymphoma.

Seminars in cancer biology

Birgitta S.
PMID: 22082693
Semin Cancer Biol. 2011 Nov;21(5):291-2. doi: 10.1016/j.semcancer.2011.10.006. Epub 2011 Oct 28.

No abstract available.

Cite
Birgitta S. Mantle cell lymphoma. Semin Cancer Biol. 2011;21(5):291-2doi: 10.1016/j.semcancer.2011.10.006.
Birgitta, S. (2011). Mantle cell lymphoma. Seminars in cancer biology, 21(5), 291-2. https://doi.org/10.1016/j.semcancer.2011.10.006
Birgitta, Sander. "Mantle cell lymphoma." Seminars in cancer biology vol. 21,5 (2011): 291-2. doi: https://doi.org/10.1016/j.semcancer.2011.10.006
Birgitta S. Mantle cell lymphoma. Semin Cancer Biol. 2011 Nov;21(5):291-2. doi: 10.1016/j.semcancer.2011.10.006. Epub 2011 Oct 28. PMID: 22082693.
Copy Download .nbib Format: NLM
Treatment of younger patients with mantle cell lymphoma.

Seminars in hematology

Harel S, Delarue R, Ribrag V, Dreyling M, Hermine O.
PMID: 21782062
Semin Hematol. 2011 Jul;48(3):194-207. doi: 10.1053/j.seminhematol.2011.06.002.

Mantle cell lymphoma (MCL) is an individualized entity that is well characterized at the molecular level and considered to be a disease of elderly patients. However, about half of patients are less than 65 years of age and may...

Cite
Harel S, Delarue R, Ribrag V, et al. Treatment of younger patients with mantle cell lymphoma. Semin Hematol. 2011;48(3):194-207doi: 10.1053/j.seminhematol.2011.06.002.
Harel, S., Delarue, R., Ribrag, V., Dreyling, M., & Hermine, O. (2011). Treatment of younger patients with mantle cell lymphoma. Seminars in hematology, 48(3), 194-207. https://doi.org/10.1053/j.seminhematol.2011.06.002
Harel, Stéphanie, et al. "Treatment of younger patients with mantle cell lymphoma." Seminars in hematology vol. 48,3 (2011): 194-207. doi: https://doi.org/10.1053/j.seminhematol.2011.06.002
Harel S, Delarue R, Ribrag V, Dreyling M, Hermine O. Treatment of younger patients with mantle cell lymphoma. Semin Hematol. 2011 Jul;48(3):194-207. doi: 10.1053/j.seminhematol.2011.06.002. PMID: 21782062.
Copy Download .nbib Format: NLM
Indolent mantle cell lymphoma.

Leukemia & lymphoma

Hsi ED, Martin P.
PMID: 23927395
Leuk Lymphoma. 2014 Apr;55(4):761-7. doi: 10.3109/10428194.2013.815353. Epub 2013 Sep 24.

Over the past decade, it has become increasingly clear that mantle cell lymphoma (MCL) is a more heterogeneous disease than originally recognized. Several groups have reported on a subgroup of patients with a less aggressive course than expected resulting...

Cite
Hsi ED, Martin P. Indolent mantle cell lymphoma. Leuk Lymphoma. 2013;55(4):761-7doi: 10.3109/10428194.2013.815353.
Hsi, E. D., & Martin, P. (2014). Indolent mantle cell lymphoma. Leukemia & lymphoma, 55(4), 761-7. https://doi.org/10.3109/10428194.2013.815353
Hsi, Eric D, and Martin, Peter. "Indolent mantle cell lymphoma." Leukemia & lymphoma vol. 55,4 (2014): 761-7. doi: https://doi.org/10.3109/10428194.2013.815353
Hsi ED, Martin P. Indolent mantle cell lymphoma. Leuk Lymphoma. 2014 Apr;55(4):761-7. doi: 10.3109/10428194.2013.815353. Epub 2013 Sep 24. PMID: 23927395.
Copy Download .nbib Format: NLM
Smoldering mantle cell lymphoma.

Journal of experimental & clinical cancer research : CR

Ye H, Desai A, Zeng D, Nomie K, Romaguera J, Ahmed M, Wang ML.
PMID: 29246179
J Exp Clin Cancer Res. 2017 Dec 15;36(1):185. doi: 10.1186/s13046-017-0652-8.

BACKGROUND: Mantle cell lymphoma (MCL) is an aggressive disease, with poor prognosis and a limited survival. However, some patients with indolent MCL can survive beyond 7~10 years. These patients remain largely asymptomatic and can be in observation for a...

Cite
Ye H, Desai A, Zeng D, et al. Smoldering mantle cell lymphoma. J Exp Clin Cancer Res. 2017;36(1):185doi: 10.1186/s13046-017-0652-8.
Ye, H., Desai, A., Zeng, D., Nomie, K., Romaguera, J., Ahmed, M., & Wang, M. L. (2017). Smoldering mantle cell lymphoma. Journal of experimental & clinical cancer research : CR, 36(1), 185. https://doi.org/10.1186/s13046-017-0652-8
Ye, Haige, et al. "Smoldering mantle cell lymphoma." Journal of experimental & clinical cancer research : CR vol. 36,1 (2017): 185. doi: https://doi.org/10.1186/s13046-017-0652-8
Ye H, Desai A, Zeng D, Nomie K, Romaguera J, Ahmed M, Wang ML. Smoldering mantle cell lymphoma. J Exp Clin Cancer Res. 2017 Dec 15;36(1):185. doi: 10.1186/s13046-017-0652-8. PMID: 29246179; PMCID: PMC5732450.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13 entries